These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 5142057)

  • 1. Evaluation of select criteria for the diagnosis of primary aldosteronism in normokalemic hypertension.
    Cangiano JL; Gould AB; Vertes V
    Am J Med Sci; 1971 Nov; 262(5):261-7. PubMed ID: 5142057
    [No Abstract]   [Full Text] [Related]  

  • 2. DOCA test for aldosteronism: its usefulness and implications.
    Rodríguez JA; Lopez JM; Biglieri EG
    Hypertension; 1981; 3(6 Pt 2):II-102-6. PubMed ID: 7028610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary aldosteronism: experience with current diagnostic criteria and surgical treatment in fourteen patients.
    Rhamy RK; McCoy RM; Scott HW; Fishman LM; Michelakis AM; Liddle GW
    Ann Surg; 1968 May; 167(5):718-27. PubMed ID: 5646293
    [No Abstract]   [Full Text] [Related]  

  • 4. Normokalemic hyperaldosteronism in patients with resistant hypertension.
    Benchetrit S; Bernheim J; Podjarny E
    Isr Med Assoc J; 2002 Jan; 4(1):17-20. PubMed ID: 11802302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indicators of mineralocorticoid excess in the evaluation of primary aldosteronism.
    Balaş M; Zosin I; Maser-Gluth C; Hermsen D; Cupisti K; Schott M; Schinner S; Knoefel WT; Scherbaum WA; Willenberg HS
    Hypertens Res; 2010 Aug; 33(8):850-6. PubMed ID: 20520614
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of suppressed renin activity and of normokalemic primary aldosteronism in hypertensive Negro patients.
    Creditor MC; Loschky UK
    Circulation; 1968 Jun; 37(6):1027-31. PubMed ID: 5653045
    [No Abstract]   [Full Text] [Related]  

  • 7. [Diagnosis and treatment outcome in primary aldosteronism based on a retrospective analysis of 187 cases].
    Szücs N; Gláz E; Varga I; Tóth M; Kiss R; Patócs A; Jakab C; Perner F; Járay J; Horányi J; Dabasi G; Molnár F; Major L; Füto L; Rácz K; Tulassay Z
    Orv Hetil; 2006 Jan; 147(2):51-9. PubMed ID: 16509213
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of primary aldosteronism in unselected hypertensive populations: screening and definitive diagnosis.
    Ganguly A
    J Clin Endocrinol Metab; 2001 Aug; 86(8):4002-4. PubMed ID: 11502849
    [No Abstract]   [Full Text] [Related]  

  • 9. A calcified aldosterone-producing tumor in a hypertensive, normokalemic, prepubertal girl.
    Kelch RP; Connors MH; Kaplan SL; Biglieri EG; Grumbach MM
    J Pediatr; 1973 Sep; 83(3):432-7. PubMed ID: 4725146
    [No Abstract]   [Full Text] [Related]  

  • 10. Primary aldosteronism in a hypertensive acromegalic patient.
    Dluhy RG; Williams GH
    J Clin Endocrinol Metab; 1969 Oct; 29(10):1319-24. PubMed ID: 4311080
    [No Abstract]   [Full Text] [Related]  

  • 11. Studies on curable hypertension: special reference to renovascular hypertension and primary aldosteronism.
    Oda T
    Jpn Circ J; 1969 Dec; 33(12):1621-6. PubMed ID: 5396206
    [No Abstract]   [Full Text] [Related]  

  • 12. Hypokalemia in the hypertensive patient, with observations on the incidence of primary aldosteronism.
    Kaplan NM
    Ann Intern Med; 1967 Jun; 66(6):1079-90. PubMed ID: 6027943
    [No Abstract]   [Full Text] [Related]  

  • 13. [The importance of primary aldosteronism as cause of "essential" hypertension].
    Siegenthaler W; Baumann K; Kiepenheuer K; Schönbeck M; Rhomberg F; Gysling E; Weidmann P; Werning C
    Schweiz Med Wochenschr; 1969 Jun; 99(23):825-8. PubMed ID: 5784017
    [No Abstract]   [Full Text] [Related]  

  • 14. Effect of posture on the plasma concentrations of aldosterone in hypertension and primary hyperaldosteronism.
    Biglieri EG
    Nephron; 1979; 23(2-3):112-5. PubMed ID: 220544
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Commentary on incidence of primary aldosteronism: current estimations based on objective data.
    Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):152-4. PubMed ID: 4884278
    [No Abstract]   [Full Text] [Related]  

  • 16. Evaluation of renal vascular hypertension and primary hyperaldosteronism.
    Calif Med; 1971 Dec; 115(6):40-7. PubMed ID: 5132525
    [No Abstract]   [Full Text] [Related]  

  • 17. Plasma renin activity and aldosterone secretion rate in hypertension. The distinction between primary and secondary hyperaldosteronism.
    Nielsen I; Jacobsen J
    Acta Med Scand; 1970 May; 187(5):401-9. PubMed ID: 5526958
    [No Abstract]   [Full Text] [Related]  

  • 18. [Current problems in primary aldosteronism--4 cases of normokalemic primary aldosteronism (1st degree) caused by adenoma and 3 cases of aldosteronism, 1st degree, caused by hyperplasia (2 hypokalemic cases, a normokalemic case)].
    Oda T
    Naika; 1969 Oct; 24(4):713-24. PubMed ID: 5358678
    [No Abstract]   [Full Text] [Related]  

  • 19. Plasma renin activity in the diagnosis of primary aldosteronism: failure to distinguish primary aldosteronism from essential hypertension.
    Jose A; Kaplan NM
    Arch Intern Med; 1969 Feb; 123(2):141-6. PubMed ID: 5812600
    [No Abstract]   [Full Text] [Related]  

  • 20. Increased urinary excretion of the epithelial Na channel activator prostasin in patients with primary aldosteronism.
    Pizzolo F; Chiecchi L; Morandini F; Castagna A; Zorzi F; Zaltron C; Pattini P; Chiariello C; Salvagno G; Olivieri O
    J Hypertens; 2017 Feb; 35(2):355-361. PubMed ID: 27841781
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.